Skip to main content

Table 1 Demographics

From: Morning versus evening dosing of desloratadine in seasonal allergic rhinitis: a randomized controlled study [ISRCTN23032971].

  Treatment groups  
Demographic Characteristics AM-group (n = 336) PM-group (n = 327) p-value
Age (years)    
Mean (SD) 35.4 (11.0) 36.5 (12.0) 0.232a
Min-Max 18–69 18–75  
Age Group (years)    
18–29 115 (34.2 %) 113 (34.6 %)  
30–39 113 (33.6 %) 95 (29.1 %)  
40–49 70 (20.8 %) 66 (20.2 %)  
≥ 50 38 (11.3 %) 53 (16.2 %)  
Sex    
Male (%) 152 (45) 163 (50) 0.235b
Female (%) 184 (55) 164 (50)  
Duration of SAR History (years)    
Mean (SD) 14.2 (9.2) 14.4 (10.3) 0.662a
Min-Max 2–50 1–55c  
  1. a t-test for differences between the means of the two treatment groups
  2. b χ2-test for the distribution between the two groups
  3. c One patient in the PM-group had only one year duration of SAR history although the inclusion criterion was 2 years